New advances in NMDA receptor pharmacology
- 12 October 2011
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 32 (12), 726-733
- https://doi.org/10.1016/j.tips.2011.08.003
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyaminesThe EMBO Journal, 2011
- Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptorsNature, 2011
- Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptorsNature Communications, 2011
- A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsNature Communications, 2010
- A Novel Family of Negative and Positive Allosteric Modulators of NMDA ReceptorsJournal of Pharmacology and Experimental Therapeutics, 2010
- Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-Selective N-Methyl-d-aspartate Receptor AntagonistsJournal of Medicinal Chemistry, 2010
- X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptorNature, 2009
- N-Methyl-d-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 SynapseJournal of Pharmacology and Experimental Therapeutics, 2009
- Allosteric modulators of NR2B‐containing NMDA receptors: molecular mechanisms and therapeutic potentialBritish Journal of Pharmacology, 2009
- Subunit‐specific mechanisms and proton sensitivity of NMDA receptor channel blockThe Journal of Physiology, 2007